## BACKGROUND. In early phase I1 trials in advanced pancreatic cancer, gemcitabine demonstrated modest antitumor activity. The investigators in these studies reported that gemcitabine should be studied further in view of the degree and frequency of symptomatic improvement observed, the durability o
Gemcitabine and oxaliplatin combination chemotherapy in 30 patients with advanced pancreatic carcinoma
β Scribed by Fan Zhao; Jianhua Miao; Di Zhao; Shubo Chen
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 191 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1610-1979
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. In early phase I1 trials in advanced pancreatic cancer, gemcitabine demonstrated modest antitumor activity. The investigators in these studies reported that gemcitabine should be studied further in view of the degree and frequency of symptomatic improvement observed, the durability o
## Background: The objective of this phase ii study was to evaluate the concept of sequential chemotherapy in the treatment of patients with advanced nonsmall cell lung carcinoma (nsclc) by the administration of carboplatin plus gemcitabine followed by of paclitaxel. ## Methods: Patients with sta